Detalhe da pesquisa
1.
Histologic correlates of "Choroidal abnormalities" in Neurofibromatosis type 1 (NF1).
Acta Neuropathol
; 147(1): 71, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38607446
2.
N-terminus DUX4-immunohistochemistry is a reliable methodology for the diagnosis of DUX4-fused B-lymphoblastic leukemia/lymphoma (N-terminus DUX4 IHC for DUX4-fused B-ALL).
Genes Chromosomes Cancer
; 61(8): 449-458, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35218117
3.
Insulator dysfunction and oncogene activation in IDH mutant gliomas.
Nature
; 529(7584): 110-4, 2016 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26700815
4.
Myositis associated with carbon monoxide poisoning.
Undersea Hyperb Med
; 46(1): 63-67, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154686
5.
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome.
Acta Neuropathol
; 136(5): 779-792, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30123936
6.
Virus vector-mediated genetic modification of brain tumor stromal cells after intravenous delivery.
J Neurooncol
; 139(2): 293-305, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29767307
7.
Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model.
Proc Natl Acad Sci U S A
; 112(47): 14676-81, 2015 Nov 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26554010
8.
Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells.
Cancer Cell
; 13(2): 105-16, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18242511
9.
Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2.
J Med Genet
; 52(8): 557-62, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26104281
10.
Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy.
Mol Vis
; 21: 673-87, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26120272
11.
Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.
Am J Med Genet A
; 161A(3): 405-16, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23401320
12.
Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma.
Mol Ther
; 20(1): 37-45, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21915104
13.
Hearing improvement after bevacizumab in patients with neurofibromatosis type 2.
N Engl J Med
; 361(4): 358-67, 2009 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-19587327
14.
Consensus recommendations for current treatments and accelerating clinical trials for patients with neurofibromatosis type 2.
Am J Med Genet A
; 158A(1): 24-41, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22140088
15.
An intraoperative multimodal neurophysiologic approach to successful resection of precentral gyrus epileptogenic lesions.
Epilepsia
; 53(4): e75-9, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22309192
16.
Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas.
Neuropathology
; 32(6): 611-6, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22394059
17.
Combined tumor and immune signals from genomes or transcriptomes predict outcomes of checkpoint inhibition in melanoma.
Cell Rep Med
; 3(2): 100500, 2022 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35243413
18.
Superficial neurofibromas in the setting of schwannomatosis: nosologic implications.
Acta Neuropathol
; 121(5): 663-8, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21191601
19.
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK.
PLoS One
; 16(7): e0252048, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34264955
20.
Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas.
J Proteome Res
; 9(1): 485-94, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19877719